Dementia: The leading predictor of death in a defined elderly population
The Cache County Study
Abstract
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementia of varying type and severity and other risk factors in a population of exceptional longevity.
Methods: Deaths were monitored over 5 years using vital statistics records and newspaper obituaries in 355 individuals with prevalent dementia and 4,328 without in Cache County, UT. Mean age was 83.3 (SD 7.0) years with dementia and 73.7 (SD 6.8) years without. History of coronary artery disease, hypertension, diabetes, and other life-shortening illness was ascertained from interviews.
Results: Death certificates implicated dementia as an important cause of death, but other data suggested a stronger association. Adjusted Cox relative hazard and PAR of death were higher with dementia than with any other illness studied. Relative hazard of death with dementia was highest at ages 65 to 74, but the high prevalence of dementia after age 85 resulted in 27% PAR among the oldest old. Mortality increased substantially with severity of dementia. Alzheimer disease shortened survival time most dramatically in younger participants, but vascular dementia posed a greater mortality risk among the oldest old.
Conclusion: In this population, dementia was the strongest predictor of mortality, with a risk two to three times those of other life-shortening illnesses.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Martin D, Miller J, Kapoor W, Arena V, Boller F. A controlled study of survival with dementia. Arch Neurol. 1987; 44: 1122–1126.
2.
Evans D, Smith L, Scherr P, Albert M, Funkenstein H, Hebert L. Risk of death from Alzheimer’s disease in a community population of older persons. Am J Epidemiol. 1991; 134: 403–412.
3.
van Dijk P, Dippel D, Habbema J. Survival of patients with dementia. J Am Geriatr Soc. 1991; 39: 603–610.
4.
Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) part XIV: demographic and clinical predictors of survival in patients with Alzheimer’s disease. Neurology. 1996; 46: 656–660.
5.
Agüero-Torres H, Fratiglioni L, Winblad B. Natural history of Alzheimer’s disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project. Int J Geriatr Psychiatry. 1998; 13: 755–766.
6.
Katzman R, Hill L, Yu E, et al. The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol. 1994; 51: 1220–1225.
7.
Aevarsson O, Svanborg A, Skoog I. Seven-year survival rate after age 85 years. Relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998; 55: 1226–1232.
8.
Østbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia. A 5-year follow-up. Neurology. 1999; 53: 521–526.
9.
Agüero-Torres H, Fratiglioni L, Guo A, Viitnen M, Winblad B. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc. 1998; 46: 444–452.
10.
Landi F, Gambassi G, Lapane K, et al. Impact of the type and severity of dementia on hospitalization and survival of the elderly. Dement Geriatr Cogn Disord. 1999; 10: 121–129.
11.
Heeren T, van Hemert A, Rooymans H. A community-based study of survival in dementia. Acta Psychiatr Scand. 1992; 8: 415–418.
12.
Barclay L, Zemcov A, Blass J, McDowell F. Factors associated with duration of survival in Alzheimer’s disease. Biol Psychiatry. 1985; 20: 86–93.
13.
Burns A, Lewis G, Jacoby R, Levy R. Factors affecting survival in Alzheimer’s disease. Psychol Med. 1991; 21: 363–370.
14.
Mölsö P, Marttila R, Rinne U. Survival and cause of death in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand. 1986; 74: 103–107.
15.
Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol. 1999; 58: 737–743.
16.
Breitner J, Wyse B, Anthony J, et al. APOE-e4 count predicts age when prevalence of AD increases, then declines. The Cache County Study. Neurology. 1999; 53: 321–331.
17.
Miech R, Breitner JCS, Zandi P, Khachaturian A, Anthony J, Mayer L. Incidence of AD may decline in the early 90s for men, later for women. Neurology. 2002; 58: 209–218.
18.
Tschanz J, Welsh-Bohmer K, Plassman B, Norton M, Wyse B, Breitner J. An Adaptation of the Modified Mini-Mental State Examination: analysis of demographic influences and normative data. The Cache County Study. Neuropsychiatry Neuropsychol Behav Neurol. 2002; 15: 28–38.
19.
Jorm J, Jacomb P. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989; 19: 1015–1022.
20.
Kawas C, Segal J, Stewart W, Corrada M, Thal L. A validation study of the Dementia Questionnaire. Arch Neurol. 1994; 51: 901–906.
21.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987.
22.
Hughes C, Berg L, Danziger W, Coben L, Martin R. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140: 566–572.
23.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian E. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984; 34: 939–944.
24.
Roman G, Tatemichi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43: 250–260.
25.
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer Disease. Arch Intern Med. 2003; 163: 1524–1528.
26.
Hosmer D Jr, Lemeshow L. Applied survival analysis. New York: Wiley, 1999.
27.
Kahn H, Sempos C. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
28.
Khachaturian A, Gallo J, Breitner JCS. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol. 2000; 53: 531–540.
29.
Asgharian M, M’Lan C, Wolfson D. Length-bias sampling with right censoring: an unconditional approach. J Am Stat Assoc. 2002; 97: 201–209.
30.
Wolfson C, Wolfson D, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001; 344: 1111–1116.
31.
Neale R, Brayne C, Johnson A. Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int Epidemiol Assoc. 2001; 30: 1383–1388.
32.
Helmer C, Joly P, Letenneur L, Commenges D, Dartigues J-F. Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol. 2001; 154: 642–648.
33.
Tilvis R, Strandberg T, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998; 46: 712–715.
34.
Koivisto A, Lempiäinen P, Koivisto K, et al. Apolipoprotein E phenotype alone does not influence survival in Alzheimer’s disease: a population-based longitudinal study. Neuroepidemiology. 2000; 19: 327–332.
35.
Skoog I, Hesse C, Aevarsson O, et al. A population study of APOE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry. 1998; 64: 37–43.
36.
Utah Mortality Database (1999 to 2001). In: [email protected]. ut.us; 2001.
37.
Centers for Disease Control. Compressed mortality. In: WISQARS leading causes of death reports, 1999–2001; http://www.cdc.gov/ncipc/wisqars/default.htm; 1999.
38.
Brookmeyer R, Corrada M, Curriero F, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002; 59: 1764–1767.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Received: August 4, 2003
Accepted: December 10, 2003
Published online: April 12, 2004
Published in print: April 13, 2004
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Cognitive Function, Healthy Lifestyle, and All-Cause Mortality among Chinese Older Adults: A Longitudinal Prospective Study, Nutrients, 16, 9, (1297), (2024).https://doi.org/10.3390/nu16091297
- Mortality rate of pulmonary infection in senile dementia patients: A systematic review and meta-analysis, Medicine, 103, 38, (e39816), (2024).https://doi.org/10.1097/MD.0000000000039816
- Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare, JAMA Network Open, 7, 9, (e2427610), (2024).https://doi.org/10.1001/jamanetworkopen.2024.27610
- Effects of Aerobic Exercise on Serum Levels of Cathepsin B and Verbal Memory Function in Young and Older Adult Male Football Players, The Neuroscience Journal of Shefaye Khatam, 12, 1, (58-66), (2023).https://doi.org/10.61186/shefa.12.1.58
- Longitudinal assessment of the eating pattern of people with dementia and its association with problems for feeding and malnutrition: a prospective follow-up study protocol, BMJ Open, 13, 5, (e068790), (2023).https://doi.org/10.1136/bmjopen-2022-068790
- Whole-genome sequencing analysis of suicide deaths integrating brain-regulatory eQTLs data to identify risk loci and genes, Molecular Psychiatry, 28, 9, (3909-3919), (2023).https://doi.org/10.1038/s41380-023-02282-x
- Canadian Health Care Providers’ Perspectives on Working with Older Homeless Adults in Outreach Settings, Canadian Journal on Aging / La Revue canadienne du vieillissement, 43, 1, (23-32), (2023).https://doi.org/10.1017/S0714980823000405
- Demenz und Palliative Care, Palliative Care, (371-385), (2023).https://doi.org/10.1007/978-3-662-66043-0_17
- Probleme der Schmerzerkennung bei alten Menschen mit Demenz, Schmerzbehandlung in der Palliativmedizin, (59-65), (2023).https://doi.org/10.1007/978-3-662-64329-7_9
- Biological aging processes underlying cognitive decline and neurodegenerative disease, Journal of Clinical Investigation, 132, 10, (2022).https://doi.org/10.1172/JCI158453
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.